D-0560-2016 Class II Terminated
FDA drug recall D-0560-2016 was initiated by PD-Rx Pharmaceuticals, Inc. on Apr 29, 2015 and is designated Class II. Reason for recall: cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm did not adequately investigate customer complaints. The recall status is terminated (terminated Dec 23, 2016). Affected quantity: 45,022 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 13, 2016
- Initiation Date
- Apr 29, 2015
- Termination Date
- Dec 23, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 45,022 bottles
Product description
Azithromycin Tablets, USP, 250 mg, Rx Only, packaged in a) 2 count and b) 4 count bottles, Packaged by: PD-RX Pharmaceuticals, Inc., Oklahoma City, OK, 73127, Mfg: Wockhardt Ltd., Mumbai, India, NDC: a) 55289-964-02, b) 55289-964-04.
Reason for recall
cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm did not adequately investigate customer complaints.
Distribution pattern
Nationwide
Code information
Lot #s: a) J12A48, Exp 10/14, L12A23, Exp 12/14, A13G04, A13H14, Exp 01/15, B13E97, Exp 02/15, C13B55, Exp 03/15, J13F75, L13C93, A14F78, A14H17, B14A6, Exp 08/15, I13D47, I13G28, Exp 09/15, J13D73, J13D93 Exp 10/15, K13E18, 11/15, A14H06, C14A49, C14D01, Exp 12/15, A14B95 01/16.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0560-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026